Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.69 EUR | +1.08% | -7.68% | +51.29% |
Apr. 25 | Onward Medical N.V. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Apr. 02 | Onward Medical Seeks US FDA Nod to Market Spinal Cord Stimulation Therapy | MT |
Sales 2023 * | 1.8M 1.93M | Sales 2024 * | 4.95M 5.32M | Capitalization | 161M 173M |
---|---|---|---|---|---|
Net income 2023 * | -33M -35.43M | Net income 2024 * | -35M -37.58M | EV / Sales 2023 * | 82.6 x |
Net cash position 2023 * | 12.07M 12.96M | Net Debt 2024 * | 8.67M 9.31M | EV / Sales 2024 * | 34.2 x |
P/E ratio 2023 * |
-4.25
x | P/E ratio 2024 * |
-4.14
x | Employees | 96 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 71.81% |
1 day | -0.43% | ||
1 week | -9.06% | ||
Current month | -3.35% | ||
1 month | -4.74% | ||
3 months | +99.14% | ||
6 months | +46.67% | ||
Current year | +49.03% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 14-11-30 | |
Vincent Delattre
FOU | Founder | - | - |
David Marver
CEO | Chief Executive Officer | - | 19-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fredericus Colen
BRD | Director/Board Member | 72 | 16-12-31 |
Jan Öhrström
CHM | Chairman | 67 | 16-04-18 |
Regina Hodits
BRD | Director/Board Member | 54 | 16-04-18 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 4.69 | +1.08% | 57 088 |
24-04-25 | 4.64 | -4.33% | 117,097 |
24-04-24 | 4.85 | -4.15% | 92,312 |
24-04-23 | 5.06 | +0.80% | 20,459 |
24-04-22 | 5.02 | -1.18% | 52,428 |
Real-time Euronext Bruxelles, April 26, 2024 at 05:37 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+49.03% | 172M | |
+72.64% | 12.34B | |
-18.30% | 7.96B | |
+15.38% | 7.16B | |
+4.86% | 5.72B | |
+6.51% | 5.03B | |
+21.99% | 4.35B | |
-21.67% | 3.99B | |
-41.36% | 2.21B | |
+1.36% | 2.01B |
- Stock Market
- Equities
- ONWD Stock